BRAIN CANCER
Clinical trials for BRAIN CANCER explained in plain language.
Never miss a new study
Get alerted when new BRAIN CANCER trials appear
Sign up with your email to follow new studies for BRAIN CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Nanoparticles may help radiation zap stubborn brain tumors
Disease control OngoingThis study tests whether adding AGuIX gadolinium-based nanoparticles to standard stereotactic radiation can better control brain metastases that are at high risk of coming back after radiation alone. About 134 adults with brain tumors from cancers like melanoma, lung, breast, or …
Matched conditions: BRAIN CANCER
Phase: PHASE2 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated May 26, 2026 04:08 UTC
-
Engineered immune cells take on deadly brain tumors in new trial
Disease control ENROLLING_BY_INVITATIONThis early-stage trial tests a personalized treatment for glioblastoma, an aggressive brain cancer. It uses a patient's own immune cells, modified to better recognize and attack the tumor, combined with chemotherapy. The study aims to check safety and see if the treatment can shr…
Matched conditions: BRAIN CANCER
Phase: PHASE1 • Sponsor: Shenzhen Geno-Immune Medical Institute • Aim: Disease control
Last updated May 26, 2026 04:06 UTC
-
New drug ST101 tested in patients with advanced cancers
Disease control OngoingThis study tests a new drug called ST101 in people with advanced solid tumors that cannot be removed by surgery or have spread. The goal is to find a safe dose and see if the drug can shrink tumors. About 125 adults with cancers like glioblastoma, melanoma, breast, or prostate ca…
Matched conditions: BRAIN CANCER
Phase: PHASE1, PHASE2 • Sponsor: Sapience Therapeutics • Aim: Disease control
Last updated May 26, 2026 03:55 UTC
-
Virus therapy takes on brain cancer in early trial
Disease control OngoingThis early-phase study tests a genetically engineered virus (rQNestin34.5v.2) that targets and kills brain tumor cells. About 62 adults with recurrent malignant glioma will receive the virus injected directly into the tumor, sometimes with a drug called cyclophosphamide to boost …
Matched conditions: BRAIN CANCER
Phase: PHASE1 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated May 19, 2026 11:59 UTC
-
AI takes on human experts in cancer diagnosis showdown
Diagnosis ENROLLING_BY_INVITATIONThis study compares a new AI system, COSMO, against human pathologists to see which can more accurately diagnose brain, lung, and kidney cancers from tissue slides. About 30 pathologists will review up to 300 de-identified images, while the AI analyzes the same cases independentl…
Matched conditions: BRAIN CANCER
Sponsor: Harvard Medical School (HMS and HSDM) • Aim: Diagnosis
Last updated May 22, 2026 13:53 UTC
-
Robot head holder aimed to steady brain cancer patients during radiation
Knowledge-focused TerminatedThis study was designed to create a robotic system that keeps the head still during whole brain radiation therapy for brain cancer patients. The goal was to improve treatment accuracy by measuring how often the head stays within a tiny target zone. However, the study was withdraw…
Matched conditions: BRAIN CANCER
Phase: NA • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Knowledge-focused
Last updated May 26, 2026 04:04 UTC
-
Experimental drug targets brain tumors in early trial
Knowledge-focused OngoingThis early-phase study tests the drug pembrolizumab in 60 adults with recurrent glioblastoma, an aggressive brain cancer. The main goal is to measure immune cell changes in the tumor and check for side effects. This is not a cure; it aims to gather information on how the drug wor…
Matched conditions: BRAIN CANCER
Phase: PHASE1 • Sponsor: Dana-Farber Cancer Institute • Aim: Knowledge-focused
Last updated May 26, 2026 04:03 UTC
-
Brain cancer communication study seeks to bridge Doctor-Patient gap
Knowledge-focused OngoingThis study looks at how doctors share information about brain tumors, scan results, and treatment choices with patients and their caregivers. Researchers hope to learn what helps or hinders clear communication about prognosis and care goals. About 309 people with glioblastoma, th…
Matched conditions: BRAIN CANCER
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated May 26, 2026 03:56 UTC
-
New PET tracer could light up brain tumors
Knowledge-focused OngoingThis study tests a new imaging tracer for PET scans to see if it can help take pictures of brain tumors. Seventeen adults with malignant brain tumors or pituitary adenomas will receive a very small dose of the tracer. The goal is to learn how the tracer spreads and leaves the bod…
Matched conditions: BRAIN CANCER
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated May 22, 2026 14:04 UTC